Pharmacokinetics of Maraviroc, Raltegravir, Darunavir, and Etravirine in the Semen of HIV-Infected Men

被引：12
|
作者：
Antoniou, Tony [1 ,2 ]
Hasan, Sumaira [3 ]
Loutfy, Mona R. [4 ,5 ,6 ]
Kovacs, Colin [5 ,7 ]
Brunetta, Jason [7 ]
Smith, Graham [7 ]
Halpenny, Roberta [7 ]
La Porte, Charles [3 ]
机构：
[1] St Michaels Hosp, Dept Family & Community Med, Toronto, ON M5B 1W8, Canada
[2] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada
[3] Ottawa Hosp, Res Inst, Ottawa, ON, Canada
[4] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada
[5] Univ Toronto, Dept Med, Toronto, ON, Canada
[6] Womens Coll Hosp, Womens Coll Res Inst, Toronto, ON M5S 1B2, Canada
[7] Maple Leaf Med Clin, Toronto, ON, Canada
来源：
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 2013年 / 62卷 / 02期
关键词：
MULTIPLE-DOSE PHARMACOKINETICS; MALE GENITAL-TRACT; RECTAL TISSUE; NEGATIVE MEN; SINGLE; SANCTUARY;
D O I：
10.1097/QAI.0b013e31827a0d71
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：E58 / E60
页数：3
相关论文
共 50 条
  • [31] Pharmacokinetics of Raltegravir in HIV-Infected Patients on Rifampicin-Based Antitubercular Therapy
    Taburet, Anne-Marie
    Sauvageon, Helene
    Grinsztejn, Beatriz
    Assuied, Alex
    Veloso, Valdilea
    Pilotto, Jose Henrique
    De Castro, Nathalie
    Grondin, Carine
    Fagard, Catherine
    Molina, Jean-Michel
    CLINICAL INFECTIOUS DISEASES, 2015, 61 (08) : 1328 - 1335
  • [32] Pharmacokinetics of Once Versus Twice Daily Darunavir in Pregnant HIV-Infected Women
    Stek, Alice
    Best, Brookie M.
    Wang, Jiajia
    Capparelli, Edmund V.
    Burchett, Sandra K.
    Kreitchmann, Regis
    Rungruengthanakit, Kittipong
    Cressey, Tim R.
    Mofenson, Lynne M.
    Smith, Elizabeth
    Shapiro, David
    Mirochnick, Mark
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2015, 70 (01) : 33 - 41
  • [33] RALTEGRAVIR USE IN HIV-INFECTED PATIENTS
    Silvia Elena, Garcia-Ramos
    Garcia-Valdecasas Maria, Fernandez-Pacheco
    Perrin Rosario, Santolaya
    ATENCION FARMACEUTICA, 2011, 13 (04): : 244 - 244
  • [34] Effect of Milk Thistle on the Pharmacokinetics of Darunavir-Ritonavir in HIV-Infected Patients
    Molto, Jose
    Valle, Marta
    Miranda, Cristina
    Cedeno, Samandhy
    Negredo, Eugenia
    Clotet, Bonaventura
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (06) : 2837 - 2841
  • [35] Influence of darunavir coadministration on nevirapine pharmacokinetics in HIV-infected patients: a population approach
    Dailly, E.
    Raffi, F.
    Perre, P.
    Martin, J.
    Deslandes, G.
    Jolliet, P.
    HIV MEDICINE, 2009, 10 (09) : 586 - 589
  • [36] Etravirine concentrations in CSF in HIV-infected patients
    Tiraboschi, J. M.
    Niubo, J.
    Vila, A.
    Perez-Pujol, S.
    Podzamczer, D.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2012, 67 (06) : 1446 - 1448
  • [37] Dual therapy with fixed dose combination of darunavir/ritonavir plus raltegravir in HIV-infected patients in Argentina
    Rombini, F.
    Cecchini, D. M.
    Uruena, A.
    Vecchio, C.
    Huberman, M.
    Cassetti, I.
    HIV MEDICINE, 2019, 20 : 66 - 66
  • [38] Facial botryomycosis-like pyoderma in an HIV-infected patient: remission after initiation of darunavir and raltegravir
    Eyer-Silva, Walter de Araujo
    Rosa da Silva, Guilherme Almeida
    de Almeida Ferry, Fernando Raphael
    da Cunha Pinto, Jorge Francisco
    REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL, 2017, 50 (02) : 277 - 279
  • [39] Raltegravir, maraviroc, etravirine: an effective protease inhibitor and nucleoside reverse transcriptase inhibitor-sparing regimen for salvage therapy in HIV-infected patients with triple-class experience
    Nozza, Silvia
    Galli, Laura
    Visco, Francesca
    Soria, Alessandro
    Canducci, Filippo
    Salpietro, Stefania
    Gianotti, Nicola
    Bigoloni, Alba
    Della Torre, Liviana
    Tambussi, Giuseppe
    Lazzarin, Adriano
    Castagna, Antonella
    AIDS, 2010, 24 (06) : 924 - 928
  • [40] HIV RNA suppression rates after 24 weeks of treatment with etravirine, darunavir/ritonavir and raltegravir in the etravirine early access programme
    Florence, E.
    De Wit, S.
    Castagna, A.
    Ribera, E.
    Hill, A.
    Vanaken, H.
    van Delft, Y.
    Marks, S.
    INTERNATIONAL JOURNAL OF STD & AIDS, 2010, 21 (03) : 224 - 225
12345